Sullivan Mark D, Wilson Lauren, Amick Matthew, Miller-Matero Lisa R, Chrusciel Timothy, Salas Joanne, Zabel Celeste, Lustman Patrick J, Ahmedani Brian, Carpenter Ryan W, Scherrer Jeffrey F
Department of Psychiatry and Behavioral Science, University of Washington School of Medicine, Seattle, WA, United States.
Department of Family and Community Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States.
Pain. 2024 Oct 1;165(10):2379-2386. doi: 10.1097/j.pain.0000000000003286. Epub 2024 Jun 4.
Post-traumatic stress disorder (PTSD) is common in patients with chronic pain, adversely affects chronic pain outcomes, and is associated with opioid use and adverse opioid outcomes. Social support is a robust predictor of PTSD incidence and course as well as chronic pain outcome. We determined whether the association between PTSD and persistent opioid use was modified by emotional support in a cohort of patients receiving opioids for noncancer pain. Eligible participants were ≥18 years and had completed a new period of prescription opioid use lasting 30 to 90 days. Bivariate associations between cohort characteristics and each key variable was assessed using χ 2 tests for categorical variables and t -tests for continuous variables. Interaction between PTSD and emotional support was assessed by a priori stratification on low vs high emotional support. Participants (n = 808) were 53.6 (SD ± 11.6) years of age, 69.8% female, 69.6% White, and 26.4% African American. Overall, 17.2% had probable PTSD. High emotional support was significantly ( P < 0.0001) more common among those without probable PTSD. Prescription opioid use at 6-month follow-up was significantly ( P = 0.0368) more common among patients with vs without probable PTSD. In fully adjusted models, PTSD was no longer associated with opioid use at 6-month follow-up among participants with high emotional support. Among those with lower emotional support, PTSD was significantly associated with opioid use at 6-month follow-up in unadjusted (odds ratio = 2.40; 95% confidence interval: 1.24-4.64) and adjusted models (odds ratio = 2.39; 95% confidence interval: 1.14-4.99). Results point to the hypothesis that improvement of emotional support in vulnerable patients with chronic pain and PTSD may help reduce sustained opioid use.
创伤后应激障碍(PTSD)在慢性疼痛患者中很常见,会对慢性疼痛的治疗结果产生不利影响,并且与阿片类药物的使用及不良阿片类药物治疗结果相关。社会支持是PTSD发病率和病程以及慢性疼痛治疗结果的有力预测指标。我们在一组接受阿片类药物治疗非癌性疼痛的患者中,确定了情绪支持是否会改变PTSD与持续使用阿片类药物之间的关联。符合条件的参与者年龄≥18岁,且完成了一个为期30至90天的新的处方阿片类药物使用期。使用χ²检验评估分类变量的队列特征与每个关键变量之间的双变量关联,使用t检验评估连续变量的双变量关联。通过对低情绪支持与高情绪支持进行先验分层来评估PTSD与情绪支持之间的相互作用。参与者(n = 808)年龄为53.6(标准差±11.6)岁,69.8%为女性,69.6%为白人,26.4%为非裔美国人。总体而言,17.2%的人可能患有PTSD。在没有可能患PTSD的人群中,高情绪支持更为常见(P < 0.0001)。在6个月随访时,使用处方阿片类药物在可能患有PTSD的患者中比未患有PTSD的患者更为常见(P = 0.0368)。在完全调整的模型中,对于情绪支持高的参与者,PTSD在6个月随访时不再与阿片类药物使用相关。在情绪支持较低的人群中,在未调整模型(比值比 = 2.40;95%置信区间:1.24 - 4.64)和调整模型(比值比 = 2.39;95%置信区间:1.14 - 4.99)中,PTSD在6个月随访时与阿片类药物使用显著相关。结果表明,对于患有慢性疼痛和PTSD的脆弱患者,改善情绪支持可能有助于减少持续使用阿片类药物这一假设。